Objective: Different parts of the advanced atherosclerotic lesion have char
acteristic differences in lipid content, but the distribution of lipid oxid
ation products has not been reported. This study provides novel data on oxy
sterol and hydroxyoctadecadienoic acids quantification in core versus cap.
It compares the lipid composition of core and cap to assess the topographic
al distribution of evidence of lipid oxidation.
Methods: Lipids and oxidised lipids were analysed by gas chromatography (GC
) and GC-mass spectrometry (GC-MS) in samples of human atheromatous lipid c
ore and fibrous cap of individual advanced atherosclerotic plaques (Stary,
Type V) in necropsy samples.
Results: The total lipid was of course massively greater in the core than i
n the cap. The oxidation products, cholest-5-en-3 beta,26-diol (26-OH-CHOL)
and cholest-5-en-3 beta,7 beta-diol (7 beta-OH-CHOL) were detected in all
the samples. 26-OH-CHOL was more abundant in the core than in the cap when
related both to wet weight and to cholesterol. 7 beta-OH-CHOL, levels were
significantly higher in the core than in the cap when related to wet weight
but not when related to cholesterol. Because the processing included a sod
ium borohydride reduction step, the 7 beta-OH-CHOL detected could partly or
iginate from 7-ketocholesterol or 7-hydroperoxy-cholesterol. Several isomer
ic hydroxyoctadecadienoic acids were detected in both core and cap, more in
the cap when related to cholesterol content. Most of the components of the
cap showed a high degree of cross-correlation on linear regression analysi
s, but cross-correlations were weaker for the core. The core samples contai
ned a larger proportion of linoleate relative to oleate than the fibrous ca
p.
Conclusion: The findings suggest that the different lipid and oxidised lipi
d contents of cap and core may be due to variations in oxidative activity i
n different parts of the lesion.